|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|
| Cash flows from operating activities | |||
| Loss before tax | |||
| Adjustments to reconcile loss before tax to net cash flows from operating activities: | |||
| Depreciation of right-of-use assets | |||
| Depreciation of property, plant and equipment | |||
| Amortisation of intangible assets | |||
| Impairment of plant and equipment | |||
| Onerous lease expense | |||
| Revenue settled with non-cash consideration | |||
| Loss recognised from joint venture | |||
| Finance income | |||
| Finance expenses | |||
| R&D expenditure tax credits | |||
| Share-based payment charge | |||
| Foreign exchange loss/(gain) | |||
| Changes in working capital: | |||
| (Increase)/decrease in trade receivables | |||
| Non-cash movement in trade receivables | |||
| Supplemental non-cash investing information | |||
| Capital expenditures recorded within trade payables | |||
| Capital expenditures recorded within other payables | |||
| Increase in other receivables and contract assets | |||
| (Decrease)/increase in contract liabilities and other advances | |||
| (Decrease)/increase in trade payables | |||
| Increase in other payables | |||
| Decrease/(increase) in inventories | |||
| Interest received | |||
| Interest paid | |||
| R&D expenditure tax credits received | |||
| Income taxes received | |||
| Income taxes paid | |||
| Net cash flows used in operating activities | |||
| Cash flows from investing activities | |||
| Payment for acquisition of subsidiary, net of cash acquired | |||
| Purchase of property, plant and equipment | |||
| Purchase of intangible assets | |||
| Additional investment in joint venture | |||
| Redemption of short term deposits | |||
| Cash invested in short term bank deposits | |||
| Net cash flows used in investing activities | |||
| Cash flows from financing activities | |||
| Proceeds from issue of share capital, net of transactions costs | |||
| Proceeds from issue of share capital relating to the Company's IPO and concurrent private placements, net of transaction costs | |||
| Cash paid on settlement of share based payments | |||
| Payments of obligations under lease liabilities | |||
| Net cash flows used in financing activities | |||
| Net (decrease)/increase in cash and cash equivalents | |||
| Increase in short term bank deposits | |||
| Net increase in short term bank deposits | |||
| Exchange (loss)/gain on cash and cash equivalents | |||
| Net (decrease)/increase in cash, cash equivalents and short term bank deposits including foreign exchange gains/(losses) on cash and cash equivalents | |||
| Net (decrease)/increase in cash, cash equivalents and short term bank deposits including foreign exchange gains/(losses) on cash and cash equivalents | |||
| Supplemental disclosure of operating Inflow Information | |||
| Cash flow from collaborations | |||
| Amounts invoiced during the period | |||
| Foreign exchange losses/(gains) on trade receivables | |||
| Cash and cash equivalents at the beginning of the year | |||
| Cash and cash equivalents at the end of the year |
Loading...
